@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix RNA: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: mgi:2152345; a Protein: . sub:_2 geneProductOf: mgi:109392; a RNA: . sub:_3 occursIn: obo:UBERON_0000992, species:10090; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(MGI:Taf4b) -> r(MGI:Esr2)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "To confirm the correct transcription of these hormone receptors, we measured the levels of Fshr and Esr-2, mRNAs in the ovaries of TAF4b-null mice and their littermates by quantitative real-time rtPCR at several time points (Fig. 4B-E). We found that at 3 weeks of age, when we administer estrogen and PMSG, TAF4b-null mice displayed no significant reduction of either mRNA (Fig. 4B, D). In contrast, at 17 weeks of age, when TAF4b-null ovaries have only a few recognizable follicle structures, levels of both receptors are decreased compared to wild-type and heterozygous mice (Fig. 4C, E)."; prov:wasQuotedFrom pubmed:17207475 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:17207475; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:07.910+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }